Circulating soluble CD36 as a novel biomarker for progression and prognosis of HBV-related liver diseases

BACKGROUND: Our previous study suggested CD36 may be a positive regulator of hepatitis B virus (HBV) replication in vitro. Therefore, the present study aimed to investigate whether circulating soluble CD36 (sCD36) could serve as a diagnostic and prognostic biomarker for HBV-related liver diseases ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Chunxian, Xiao, Anhua, Luo, Xiaoqing, Zheng, Enze, Li, Yiyu, Lei, Yu, Zhong, Shan, Chen, Yaxi, Yang, Ping, Tang, Zhurong, Zhou, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667018/
https://www.ncbi.nlm.nih.gov/pubmed/36406414
http://dx.doi.org/10.3389/fmicb.2022.1039614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667018/
https://www.ncbi.nlm.nih.gov/pubmed/36406414
http://dx.doi.org/10.3389/fmicb.2022.1039614

Ejemplares similares